AAV2-NLPGSGD vector system (AAV2-NLPGSGD expression system, AAV2-NLPGSGD packaging plasmid system) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi (GM) AAV2-NLPGSGD Vector system is including: 1) AAV2-NLPGSGD Rep-Cap plasmid (AAV2-NLPGSGD-RC plasmid) 2) AAV Helper plasmid 3) AAV expression vectors (overexpression or shRNA).
You can produce AAV2-NLPGSGD particle in 293T cell line in high titer using GeneMedi's AAV2-NLPGSGD Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
The tissue tropism of AAV2-NLPGSGD vector has been screened and validated in cardiac pressure overload models with high transduction efficiency, showing potential applications in targeted cardiovascular gene therapy.
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids, AAV expression Plasmids and AAV helper Plasmid.
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | First Order Discount | First Order Discount Price |
|---|---|---|---|---|---|
| P-PK81 | AAV2-NLPGSGD Vector System (Amp resistance) 1. AAV2-NLPGSGD Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Academic | 3379 | 50% | 1689.5 |
| P-PK81 | AAV2-NLPGSGD Vector System (Amp resistance) 1. AAV2-NLPGSGD Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Biotech & Pharma & Medical Device & Diagnostics | 50% | ||
| P-PK81 | AAV2-NLPGSGD Vector System (Amp resistance) 1. AAV2-NLPGSGD Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
50% | ||
| P-PK81 | AAV2-NLPGSGD Vector System (Amp resistance) 1. AAV2-NLPGSGD Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK81-Kan | AAV2-NLPGSGD Vector System (Kan resistance) 1. AAV2-NLPGSGD Rep-Cap Plasmid (Kan resistance) , ≥10mg 2. AAV Helper Plasmid (Kan resistance) , ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-RC81 | AAV2-NLPGSGD Rep-Cap
Plasmid (Amp resistance)
Size:5ug |
Academic | 2062 | 50% | 1031 |
| P-RC81 | AAV2-NLPGSGD Rep-Cap
Plasmid (Amp resistance)
Size:5ug | Biotech & Pharma & Medical Device & Diagnostics | 50% | ||
| P-RC81 | AAV2-NLPGSGD Rep-Cap
Plasmid (Amp resistance)
Size:5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
50% | ||
| P-RC81 | AAV2-NLPGSGD Rep-Cap
Plasmid (Amp resistance)
Size:≥10mg |
All | |||
| P-RC81-Kan | AAV2-NLPGSGD Rep-Cap
Plasmid(Kan resistance)
Size:≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Vector System. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Vector System currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
No data available.
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
| PurProX™ AAVEasy rapid-to-purify Spin Column | Detail |


Go to AAV
vector system
>>